NCT07449117 Effect of Striatal Temporal Interference Stimulation on Language Processing in Neurodegenerative Diseases
| NCT ID | NCT07449117 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Masaryk University |
| Condition | Mild Cognitive Impairment (MCI) Amnestic |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-03 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-03 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the immediate effects of non-invasive temporal interference stimulation (TIS) targeting the striatum on sentence processing and brain connectivity in patients with neurodegenerative diseases.
Eligibility Criteria
Inclusion Criteria: * Possible or probable Mild Cognitive Impairment with Lewy Bodies (MCI-LB), in Parkinson's Disease (MCI-PD) or Amnestic Mild Cognitive Impairment (aMCI). Exclusion Criteria: * Any severe psychiatric disorder. * History of other neurological diseases affecting the central nervous system. * Severe head trauma. * Uncompensated internal or oncological disease. * Presence of MRI-incompatible metal in the body (e.g., pacemaker).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07449117 clinical trial?
This trial is open to participants of all sexes, aged 60 Years or older, up to 80 Years, studying Mild Cognitive Impairment (MCI) Amnestic. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07449117 currently recruiting?
Yes, NCT07449117 is actively recruiting participants. Contact the research team at lubomira.novakova@ceitec.muni.cz for enrollment information.
Where is the NCT07449117 trial being conducted?
This trial is being conducted at Brno, Czechia.
Who is sponsoring the NCT07449117 clinical trial?
NCT07449117 is sponsored by Masaryk University. The trial plans to enroll 70 participants.